Consumer Sentiment Slides to a Five-Month Low as Cost-of-Living Frustration Builds

American households are growing more pessimistic about the economy. The University of Michigan’s preliminary October consumer sentiment index fell to 46.3, down from 48.1 in September and below the 47.3 reading economists had expected. It marks the weakest level in five months and underscores how persistently high prices are shaping the mood of the American consumer.

Cost of living is the common thread

Survey director Joanne Hsu said frustration over the cost of living keeps building, and that consumers across the political spectrum believe the economy has lost ground since the start of the year. With midterm elections 25 days away, sentiment improved among both Democrats and Republicans, but a decline among independents more than offset those gains.

The pain is uneven. Lower-income households and those with smaller stock portfolios, the groups with the least cushion against rising prices, saw sentiment decline this month. That divide matters: a market rally does little for the families that don’t own much of the market.

Inflation expectations are moving the wrong way

Consumers now expect prices to rise 4.7% over the next year, up from 4.6% in September and well above the 3.4% recorded in February, when the Middle East conflict and the resulting energy shock began. Long-run expectations ticked up to 3.5% from 3.4%, and they have stayed above the 2.8%–3.2% range seen in 2024. Expectations matter because they can become self-reinforcing, influencing wage demands and pricing decisions.

Energy is a major driver. Gas prices are up more than $1.50 a gallon on average since the war began, according to AAA, and have held above $4 since mid-summer.

Borrowing costs add pressure

Rates are compounding the problem. The 10-year Treasury yield has climbed above 5%, with some analysts warning it could approach 6%, a level not seen since 2000. That flows directly into household borrowing: Freddie Mac reports the average 30-year fixed mortgage rate rose to 7.4% this week, a three-year high. Concerns about a national debt now above $40 trillion are also weighing on consumer views of buying conditions.

Why it matters for investors

Consumer spending drives roughly two-thirds of U.S. economic activity, so sentiment readings are worth watching. A weak mood combined with elevated inflation expectations leaves the Federal Reserve in a difficult spot: easing is harder to justify when households expect higher prices, but tighter financial conditions risk squeezing the consumer further. Retail, housing-related, and consumer discretionary names are the most exposed if sentiment keeps deteriorating and spending follows.

What to watch next

The October figure is preliminary, and the final reading is due later this month. Investors should watch whether sentiment stabilizes or keeps sliding, whether year-ahead inflation expectations push further above 4.7%, and how the 10-year yield behaves as it flirts with higher levels. Gas prices and mortgage rates will also be telling: if they ease, the pressure on households could lift; if they keep climbing, the sentiment gap between higher- and lower-income consumers may widen further.

Xcel Brands (XELB) – Performance-Based Partnership Could Accelerate Royalty Growth


Friday, October 09, 2026

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

George Proost, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

An important evolution of the creator-commerce model. Xcel Brands announced a partnership with Paradium.AI to launch PetHelpful x Trust·Respect·Love by Cesar Millan, combining Parade’s extensive digital publishing network with Cesar Millan’s global recognition and authentic content. We believe the collaboration marks an important evolution in Xcel’s strategy, leveraging AI-powered content to convert strong consumer awareness into retail sales.

A compelling performance-based marketing model. Paradium.AI commits significant marketing resources through its media platforms to participating retailers at no cost, while Paradium.AI, Cesar Millan, and Xcel share performance-based royalties. We believe this creates an attractive proposition for retailers by providing substantial promotional support while aligning all parties’ interests around generating sales.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Resources Connection (RGP) – Pricing Holds as the Recovery Remains Elusive


Friday, October 09, 2026

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Overview. Resources Connection’s first-quarter results were within management’s revenue and gross margin outlook, while lower operating expenses helped profitability exceed our July projections. However, the Company has yet to demonstrate sustained revenue improvement. We believe pricing discipline and ongoing cost actions provide a foundation for recovery, but weak consultant utilization and recent cash consumption leave less room for an extended turnaround.

1Q27 Results. Revenue was $98.1 million compared to $120.2 million in 1Q26 and our $100 million estimate. Adjusted EBITDA was a loss of $3.6 million compared to $3.1 million in 1Q26 and our projected $5.5 million loss. Adjusted net loss was $0.16/sh. versus EPS of $0.03 in 1Q26 and our $0.22/sh. loss estimate. The earnings improvement relative to our forecast is encouraging, although it does not change the need for higher billable activity.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Alliance Resource Partners (ARLP) – Coal Operations Anchor Cash Flow as Oil and Gas Royalties Expand


Friday, October 09, 2026

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Coal fundamentals support a constructive outlook. Alliance Resource Partners is the second-largest coal producer in the eastern United States and benefits from a competitive cost structure and strong earnings visibility based on contracted sales. More than 99% of expected 2026 coal volumes are committed and priced, while approximately 85% of anticipated 2027 volumes are contracted. Growing electricity demand and a more supportive regulatory environment could extend coal-fired power plant lives and strengthen demand for thermal coal.

Royalties strengthen the growth profile. Alliance continues to expand its high-margin oil and gas royalty business, supported by more than $1 billion invested in mineral interests. The recent $206.2 million AllDale acquisition expanded its portfolio to approximately 115,680 net royalty acres, including more than 44,770 acres in the Permian Basin. We expect royalties to contribute increasingly to earnings and cash flow without the capital requirements of operated properties.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

FCC Clears SpaceX to Launch 15,000 Direct-to-Phone Satellites, Putting Wireless Carriers on Notice

The FCC approved SpaceX on Wednesday, Oct. 7, to launch and operate up to 15,000 next-generation Starlink Mobile satellites that connect directly to ordinary smartphones. SpaceX has about 650 mobile satellites in orbit today. Elon Musk said on X that the new V2 constellation will deliver more than 100 times the bandwidth of the current system.

The company says the upgraded network will deliver 5G speeds of up to 150 Mbps per user, using spectrum from T-Mobile and airwaves SpaceX purchased from EchoStar. That goes beyond patching dead zones: it is a bid to offer real mobile broadband from space.

Existing rules assumed satellite operators would lease spectrum from a terrestrial carrier, which made carriers the gatekeepers. Because SpaceX now owns roughly 65 MHz of spectrum, acquired from EchoStar in two deals totaling about $19.6 billion, the FCC waived the leasing requirement, citing competition in retail wireless service. In practice, SpaceX can sell phone service without a carrier’s sign-off, which weakens the leverage of T-Mobile, its current direct-to-cell partner. SpaceX President Gwynne Shotwell added that the spectrum has terrestrial components and the company intends to build out on the ground as well.

The timeline is long. Launches are slated to begin in late 2027, and SpaceX cannot use the EchoStar spectrum commercially until the remaining part of that deal closes, expected by Nov. 30, 2027. Half the constellation must be in orbit by Oct. 7, 2032, and the full network by Oct. 7, 2035.

Capacity is also a question. Moving from about 650 to 15,000 satellites is roughly a 23-fold increase, so a 100x bandwidth gain implies each satellite carries about four times today’s load. But 150 Mbps is a peak figure, and satellite beams share capacity across wide areas. How the network performs under heavy demand in dense cities remains unproven. That points to rural and roaming customers as the first to feel competitive pressure.

AT&T, Verizon, and T-Mobile formed a satellite-to-phone joint venture on Oct. 2, but it still needs another company’s satellites. Verizon’s and AT&T’s current satellite arrangements rely on AST SpaceMobile, whose network is not yet built. AST shares fell about 4% on the news. AT&T may be the most exposed: revenue was $126 billion in fiscal 2025, down from $134 billion in 2021, so even modest rural losses would show.

The approval came from an FCC bureau rather than the full commission, so it could be reviewed. On Oct. 29, the FCC votes on auctioning 25 MHz of spectrum for direct-to-device service, and a carrier win there would narrow SpaceX’s lead. Investors should also watch whether launches begin on schedule in late 2027. Analysts project SpaceX revenue rising from $45.1 billion in fiscal 2026 to $200 billion in fiscal 2028.

Viatris to Acquire Pacira BioSciences for $1.65 Billion, Expanding Into Non-Opioid Pain Therapies

Viatris (Nasdaq: VTRS) announced Thursday it has agreed to acquire Pacira BioSciences (Nasdaq: PCRX) for $36.50 per share in cash, an aggregate equity value of $1.65 billion. The deal gives Viatris two marketed, patent-protected non-opioid pain medicines and positions the company as a leader in a category where patients and physicians continue to look for alternatives to opioids.

Pacira’s portfolio rests on EXPAREL, a long-acting local anesthetic used to manage pain after surgery, and ZILRETTA, an extended-release injection for osteoarthritis knee pain. Company materials cite up to a 78% decrease in opioid consumption with EXPAREL, though the release notes the clinical benefit of that reduction was not demonstrated. Over the twelve months ended June 30, 2026, Pacira generated about $746 million in revenue and $177 million in adjusted EBITDA. On equity value alone, the price works out to roughly 2.2 times revenue and 9.3 times adjusted EBITDA. GAAP net income over the same period was a much smaller $14.6 million, reflecting significant amortization of acquired intangibles and stock-based compensation.

Viatris says the acquisition advances its push to build an innovative medicines business, and that the products complement its fast-acting meloxicam opportunity in pain. The company also gains Pacira’s U.S. commercial, market access, medical affairs, and research capabilities, along with a pipeline led by a Phase 2 gene therapy candidate for knee osteoarthritis. Viatris plans to apply its expertise in intellectual property and product lifecycle management to extend the portfolio’s reach, including across select international markets where it already operates.

Viatris expects to fund the deal primarily from excess cash, with the remainder from short-term borrowings, and says the impact on its gross leverage ratio will be minimal. The transaction is expected to be immediately accretive to its financial guidance metrics. It will be structured as a tender offer followed by a second-step merger at the same price, with both boards having unanimously approved and Pacira’s board recommending that shareholders tender. Closing requires that a majority of Pacira’s outstanding shares be tendered and that the regulatory waiting period expire, and is expected by the end of 2026. Once complete, Pacira will be delisted from Nasdaq. Viatris will discuss the transaction when it reports third-quarter results on November 5.

Pacira’s leadership said the company has helped nearly 20 million patients access non-opioid pain management and that Viatris’ scale and resources will help bring its therapies to more patients.

The thesis behind the deal is worth examining. Viatris highlighted its record of sustaining sales after competition arrives, a reminder that protected products do not stay protected forever and that part of what Viatris is paying for is its ability to manage that transition.

For small and microcap investors, the takeaway is that commercial-stage healthcare companies with profitable, differentiated products are drawing strategic interest at disciplined valuations. Roughly nine times adjusted EBITDA on equity value is a useful benchmark for smaller specialty pharma and medical technology companies with established revenue, and it reinforces a theme running through this year’s healthcare deal activity, including Supernus’s merger with Indivior and MiMedx’s acquisition of Sanara MedTech. Companies still in development are a different proposition, since their deal values depend far more on clinical milestones than on current earnings.

Take a moment to take a look at more emerging growth biotech companies by looking at Noble’s Research Analyst Robert LeBoyer’s coverage list.

Mortgage Rates Hit 7.4%, the Highest in Nearly Three Years

The average 30-year fixed mortgage rate reached 7.4% this week, according to Freddie Mac survey data through Wednesday, up from 7.28% a week earlier and the highest level in nearly three years. Other measures are higher still. Mortgage News Daily calculated 7.59% as of Wednesday, the Mortgage Bankers Association reported a 7.49% average for the week through Friday, and Zillow data showed a 7.52% rate on a 30-year purchase loan today.

The climb has been steady. Freddie Mac’s 30-year average was 6.65% in late August, which means borrowing costs have risen by roughly three-quarters of a percentage point in about seven weeks. The average crossed 7% in late September for the first time in nearly three years and has kept climbing. On a $400,000 loan, a 7.4% rate means principal and interest of roughly $2,770 a month, about $290 more than at the 6.3% level of a year ago.

Mortgage rates are following bond yields higher as investors worry about government spending, inflation tied to the Iran war, and ongoing economic growth. The 10-year Treasury yield has hovered around 5.3% this week, retreating slightly after briefly touching its highest level since 2002. That link to long-term yields explains why mortgage rates have kept rising even as expectations for another Fed hike in October have faded, since home loan costs track the bond market more closely than the Fed’s policy rate.

The housing market is showing the strain. One housing economist said the higher rates have unsettled the market, noting that pending home sales fell from a year earlier in both August and September, before rates even crossed 7%, and that sellers are cutting prices at a pace not seen in four years. Higher rates reduce what buyers can afford, which pushes sellers to lower prices to attract them, and it keeps many existing homeowners with lower-rate loans from listing at all.

Refinancing is not offering much of an escape either. Zillow data put the average 30-year refinance rate at 7.41% today and the 15-year at 6.76%, while 15-year purchase loans averaged 6.70%. For buyers weighing alternatives, a 5/1 adjustable-rate mortgage averaged 7.13%, only modestly below the 30-year fixed, which limits the appeal of taking on adjustable-rate risk.

Several upcoming data points will show whether rates are close to a peak: next week’s Freddie Mac survey, the September inflation report, and the Fed’s October 27 and 28 meeting, where futures see only a small chance of another hike.

For small and microcap investors, the mortgage market is a useful read on how long-term rates are feeding into the real economy. Housing-linked businesses, from builders and building products suppliers to real estate services and home improvement retailers, are typically among the first to feel higher borrowing costs, and smaller companies with less pricing power and more floating-rate debt feel it more acutely. Mortgage-related financial companies face the same pressure through lower loan volumes. Because long yields, not the Fed, are driving this move, relief is likely to depend on easing concerns about deficits and inflation rather than on the central bank pausing.

MAIA Biotechnology (MAIA) – Patient Enrollment Completed In THIO-101, Enrollment Milestone Reached In THIO-104


Thursday, October 08, 2026

Robert LeBoyer, Senior Vice President, Equity Research Analyst, Biotechnology, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

MAIA Reported Two Important Clinical Trial Milestones. MAIA announced the completion of enrollment for the Part C Expansion Stage of the THIO-101 trial. This part of THIO-101 has enrolled 150 patients. Separately, the Phase 3 THIO-104 trial reached enrollment of 65 patients, putting it on schedule to enroll 100 patients by YE2026. Reaching the full-year enrollment goal could allow an interim analysis in FY2027.

Results From THIO-101 Part C Have Been Positive To Date. As discussed in our Research Note on September 22, MAIA recently announced initial efficacy data from the THIO-101 Part C. The evaluable population, consisting of patients with at least one post-treatment evaluation by tumor scan, showed a disease control rate (DCR) of 90.5%. This far exceeds published studies that show a 25%–35% DCR for standard third-line chemotherapy regimens.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Fed Was Unanimous on the September Hike, but October Odds Have Faded

Minutes from the Federal Reserve’s September 16 meeting, released Wednesday, show that every participant agreed interest rates needed to move higher. The committee voted unanimously to raise the federal funds rate, its first increase in three years, and most members projected at least one more quarter-point hike before the end of the year.

The minutes describe a committee that saw inflation as elevated and the labor market as near full employment, with some signs of strengthening. Economic activity was expanding at a solid pace. Almost all participants judged that risks to inflation were tilted to the upside, while risks to the labor market had diminished and were now broadly balanced. That balance of risks was the basis for the hike.

But the data since that meeting has shifted the picture. Core PCE inflation, the Fed’s preferred gauge, rose 3% in August, below the 3.3% economists expected and down from 3.3% in July. Then the September jobs report came in far weaker than forecast, with just 29,000 jobs added and the unemployment rate edging up to 4.2% from 4.1%. In other words, the two conditions that justified the hike, stubborn inflation and a firming labor market, both looked softer within weeks.

Several officials had already begun tempering expectations before the jobs report. Vice Chair Philip Jefferson and New York Fed President John Williams both acknowledged that inflation remains too high but said the central bank should take time to assess whether it is on a downward path. Williams said there is no need for urgency after the September increase and that the Fed has time to gather more information. That marks a notable shift from late September, when other officials were publicly arguing that more hikes were needed. Core inflation at 3% is still well above the Fed’s 2% target, so the debate now appears to be about timing rather than direction.

Markets have adjusted accordingly. The Fed meets again October 27 and 28, and futures now price only about a 17% chance of a hike at that meeting, down from roughly two-thirds in late September. The odds of a hike in December sit near 70%, which suggests traders see the Fed pausing rather than finishing.

A pause would not necessarily bring relief to long-term borrowing costs. The 10-year Treasury yield is still near 5.3%, and much of the recent rise has reflected investors demanding higher real returns to hold long-dated debt rather than the Fed’s policy rate, a dynamic that a pause in hikes may do little to change.

For small and microcap investors, the shift matters. Roughly 32% of Russell 2000 companies carry floating-rate debt, compared with about 6% of S&P 500 companies, so changes in the expected path of short-term rates flow more directly into smaller companies’ interest costs. A pause at the current range of 3.75% to 4.00% would stabilize that expense, while a December hike would extend it. The weaker jobs data cuts both ways, since easing rate pressure helps leveraged balance sheets but a cooling labor market can hurt consumer-facing companies that depend on household spending, such as restaurant operator The ONE Group Hospitality and travel deals publisher Travelzoo.

Small Caps are Bending, Not Breaking, as Credit Stress Builds

Stocks are at records, credit markets are showing strain, and small caps are in the middle of the debate. The picture is more mixed than the headlines suggest.

The S&P 500 and Nasdaq hit record highs on Tuesday. The Russell 2000 closed at 2,830, about 8% below its third-quarter high of 3,068 but still up roughly 14% this year, after finishing 2025 near 2,482. As of July, it had also outpaced the S&P 500 over six months (16.9% versus 8.9%) and one year (20.0% versus 9.9%), according to Benzinga.

The pressure is real. The 10-year Treasury yield closed at 5.27% on Tuesday, a level not seen since 2002. JPMorgan strategists say deeply distressed leveraged loans are at their highest since March 2020, and spreads on CCC-rated bonds have passed 1,000 basis points.

Those figures describe leveraged loans and junk bonds, though, not the companies in the Russell 2000.

Where small caps stand

Small caps do carry more rate risk. Interest expense takes up 31% of EBITDA at Russell 2000 companies, versus 6.7% for the S&P 500, and about 30% of their debt is floating-rate, according to July data from The Kobeissi Letter.

But that sensitivity works in both directions. When oil prices fell and rate expectations eased this spring, the Russell 2000 gained about 11.7% in the first 20 days of April, per 24/7 Wall St. The index has since recovered about 16% from its low during the Iran war selloff, breaking out of a multi-year base near 2,000 and closing the second quarter at 3,024.

Debt is concentrated, and many companies are cushioned

Not every small cap is carrying a heavy load. A 2024 Wellington analysis found that half of the Russell 2000’s debt sits with just 10% of its companies, while 33% held net cash, versus 13% for the S&P 500.

That study predates this year’s rate moves, but it points to a market where stress is concentrated rather than universal. JPMorgan’s latest data fits that pattern: technology accounts for 39% of distressed loans, with software borrowers facing more than $100 billion of maturing debt. Nearly 40% of the index’s companies are unprofitable, which also means a majority are not.

Signs of resilience

JPMorgan CEO Jamie Dimon said weeks ago, after the Federal Reserve’s September rate hike, that the labor market’s relative strength suggested higher borrowing costs had not yet turned into broader economic stress. On Tuesday, he warned that spreads could eventually widen as governments and AI spending compete for capital.

Markets are calm for now. The VIX, Wall Street’s fear gauge, closed near 15. JPMorgan projects a 2.25% default rate this year, though it expects defaults to rise next year.

What could help

Investors will be watching the 10-year yield, CCC spreads and the Fed’s next meeting under Chair Kevin Warsh. Falling yields would ease refinancing for the many small caps with debt coming due, and third-quarter earnings should show how companies are managing interest costs. Oil, trading near $90 a barrel, is another swing factor: its drop in April helped reset rate expectations.

Credit conditions are tightening, but small caps have already shown they can rebound when pressure eases. For companies with solid balance sheets, the data point to a hurdle rather than a roadblock.

Lucky Strike Entertainment (LUCK) – Q1 Headwinds, Full-Year Outlook Intact


Wednesday, October 07, 2026

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

George Proost, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Q1 expectations reset. We are lowering our fiscal Q1 revenue and adj. EBITDA forecasts to $299.0 million and $72.5 million, down from $307.0 million and $77.0 million, respectively. The revision largely reflects softer-than-expected water-park results due to unfavorable weather, pricing, and season-pass decisions, as well as lingering disruption from the World Cup.

Water-park weakness appears fixable. While weather and an aggressive, roughly 30% price increase pressured attendance, per-capita spending improved, and labor costs declined. Management plans to recalibrate pricing, start selling season passes earlier, and further optimize admissions to position the parks for improved performance next season.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

The GEO Group (GEO) – To Redeem Debt, Extend Credit Facility


Wednesday, October 07, 2026

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Debt Redemption. The GEO Group is redeeming all of its $650 million 8.625% Senior Secured Notes due in 2029. The redemption will be funded from net proceeds of the facility sale announced Monday. We view this as a significant positive for the Company, reducing outstanding debt, eliminating interest payments, and setting the Company up to be more aggressive in its share repurchase program.

Details. The redemption price for the 2029 Senior Secured Notes will be equal to $1,043.13 per $1,000.00 original principal amount, or approximately $678 million, plus any accrued and unpaid interest. GEO is receiving a net $705 million from the facility sale and had another $55 million of cash on the balance sheet as of June 30th. The redemption of the 2029 Senior Secured Notes will occur on October 15, 2026. GEO will save some $56 million in annual interest expense.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Conduent (CNDT) – Transit Sale Closes; Deleveraging Story Advances


Wednesday, October 07, 2026

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

George Proost, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Transit sale completed. Conduent completed the previously announced sale of its public transit and fare collection business to Modaxo on October 1. In our view, the closing represents another important step in the company’s efforts to simplify its portfolio, reduce financial leverage, and focus resources on its core Commercial and Government businesses.

$125 million earmarked for debt reduction. Conduent received $140 million in cash consideration at closing and expects to use $125 million of net proceeds to repay borrowings under its revolving credit facility. We view the debt reduction favorably and believe the improved balance sheet should enhance the company’s financial flexibility as management executes its ASCEND strategy.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.